Biotech

All Articles

Ideaya bags possibility on Biocytogen bispecific ADC in $400M offer

.Ideaya Biosciences is actually wagering $400 thousand in biobucks that a bispecific antibody-drug c...

Takeda takes $140M loss on neglected epilepsy drug, boasts FDA run

.Our company actually understand that Takeda is actually expecting to find a pathway to the FDA for ...

VBI Injections files for insolvency, finds asset purchase

.Immunology biotech VBI Vaccinations is actually diverting precariously near the defining moment, al...

Celldex anti-cKIT antitoxin lower hives in yet another period 2 study

.It's hard to muscle in on a room as affordable as immunology, but Celldex Rehabs thinks that its ow...

Boehringer provides to $1.3 B for gate prevention biotech

.Boehringer Ingelheim is actually providing to $1.3 billion for Nerio Rehabs and also a preclinical ...

Ventyx's last resort for inflamed med sides in Crohn's failure

.Ventyx Biosciences' Crohn's disease medicine did not assist people accomplish remission in a phase ...

Cognition's period 2 radiate records blemish Alzheimer's possibility

.Knowledge Rehabs' period 2 SHINE test has actually taken some of the luster off the Alzheimer's ill...

BMS axes bispecific months after filing to run phase 3 test

.Bristol Myers Squibb has had a whiplash change of mind on its BCMA bispecific T-cell engager, stopp...

Charles Baum manages Terremoto as chief executive officer

.Charles Baum, M.D., Ph.D., that managed Mirati Therapies' $ 5.8 billion sale to Bristol Myers Squib...

Asarina to shut after attempts to companion Tourette's medicine neglect

.After reaching out to more than 200 companies to partner a Tourette disorder treatment that present...